For those hoping for a radical overhaul of the U.S. healthcare system – Medicare for All, for example – there’s not going to be much enthusiasm about the Biden Administration’s proposals. But, instrumental changes to public programs, including the ACA,…
Currently, value frameworks appear to be lacking in terms of their ability to move healthcare systems towards both a highly sustainable and patient-centric pathway. In particular, there may be deficiencies in how the patient voice is captured in value …
Eli Lilly is one of the pharmaceutical companies taking on the task of developing these therapies, and a new antibody therapy trial released last week proved one combination therapy to be quite effective at reducing viral load in Covid-19 patients.
There is mounting evidence that they may be resistant to neutralization by antibodies directed against earlier stains.
Last week, Israel released preliminary data on the effects of vaccination for infection and transmissibility. Early indications suggest that after vaccination, as many as 70% of people can still be infected.
In biopharma, the potential for new medications is increasing exponentially. Yet an unproductive business model threatens the future of the industry.
Over 130,000 were in the hospital with severe Covid-19 symptoms in the past two weeks. Emerging evidence suggests one cause of severe Covid-19 reaction may be autoantibodies or antibodies that attack the body and not an invading pathogen.
Two recent preprints add some nuance to our current understanding of the Covid-19 variants B.1.1.7 and B.1.351—demonstrating that viral variation isn’t an inherently disastrous development, but could become one if we don’t act accordingly.
Consistent compliance with guidance will be a tall order as many states are opposed to (re)imposing restrictions. Yet, to win the battle against Covid-19, the Biden Administration will need to accelerate vaccine distribution and, equally important, per…
Researchers estimate that as many of 76 percent of Manaus residents were infected with Covid-19 by Oct 2020—a proportion that technically exceeds the threshold for population immunity. So why is the city struggling to survive a second wave?
